Susan Catalano, founder and CSO of Cognition Therapeutics, speaks about Cognition’s clinical progress and the underlying rationale for its Alzheimer’s drug program . . .
Cognition Thinks It Has an Alzheimer’s Blockbuster
Source: Vladyslav Bobuskyi/Getty Images
![Evidence points to a leaky blood-brain barrier as an early event in brain diseases that causes neurodegeneration. [ajcity.net]](https://www.genengnews.com/wp-content/uploads/2018/10/Dec22_2016_AJCity_Alzheimer1371049413-100x70.jpg "Alzheimer’s Cognitive Dysfunction Linked to Clotting Factor")